Alnylam Pharmaceuticals, Inc. (ALNY) Revenue & EPS Growth Rates 2026

Growth Analysis - ALNY

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth65.19%

5Y CAGR49.77%

10Y CAGR56.89%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth71.24%

5Y CAGR-3.56%

10Y CAGR16.31%

Equity

1Y Growth1076.33%

5Y CAGR-4.93%

10Y CAGR-4.61%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	65.2%	42.5%	53.0%	49.8%	56.9%	27.2%	38.2%	N/A
FY 2024 Dec 31, 2024	23.0%	47.2%	38.6%	59.2%	46.2%	23.0%	36.8%	N/A
FY 2023 Dec 31, 2023	76.2%	47.2%	54.8%	89.5%	44.2%	21.7%	58.8%	N/A
FY 2022 Dec 31, 2022	22.9%	45.1%	67.8%	63.1%	31.6%	22.3%	N/A	N/A
FY 2021 Dec 31, 2021	71.3%	96.0%	124.2%	78.1%	26.1%	25.8%	N/A	N/A
FY 2020 Dec 31, 2020	124.3%	156.5%	76.3%	64.4%	17.3%	34.6%	N/A	N/A
FY 2019 Dec 31, 2019	193.4%	56.3%	67.0%	34.2%	8.1%	30.0%	N/A	N/A
FY 2018 Dec 31, 2018	-16.7%	26.0%	22.2%	9.7%	-2.5%	49.7%	N/A	N/A
FY 2017 Dec 31, 2017	90.7%	47.9%	21.2%	6.1%	5.9%	N/A	N/A	N/A
FY 2016 Dec 31, 2016	14.8%	-3.4%	-0.0%	-10.6%	5.8%	N/A	N/A	N/A
FY 2015 Dec 31, 2015	-18.7%	-6.7%	-14.9%	-16.3%	21.8%	N/A	N/A	N/A
FY 2014 Dec 31, 2014	7.2%	-13.0%	-15.1%	-12.8%	28.0%	N/A	N/A	N/A
FY 2013 Dec 31, 2013	-29.3%	-24.5%	-22.2%	-13.3%	74.9%	N/A	N/A	N/A
FY 2012 Dec 31, 2012	-19.4%	-18.3%	-12.8%	5.6%	N/A	N/A	N/A	N/A
FY 2011 Dec 31, 2011	-17.3%	-9.3%	-4.9%	25.2%	N/A	N/A	N/A	N/A
FY 2010 Dec 31, 2010	-0.5%	2.0%	25.3%	77.3%	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	4.5%	40.5%	55.1%	88.0%	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	88.9%	89.0%	156.2%	252.8%	N/A	N/A	N/A	N/A
FY 2007 Dec 31, 2007	89.0%	198.4%	128.3%	N/A	N/A	N/A	N/A	N/A
FY 2006 Dec 31, 2006	371.1%	150.9%	434.9%	N/A	N/A	N/A	N/A	N/A
FY 2005 Dec 31, 2005	33.6%	469.9%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2004 Dec 31, 2004	2330.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2003 Dec 31, 2003	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - ALNY

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Alnylam Pharmaceuticals, Inc.

Compare with peers

Explore

Growth Analysis - ALNY

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Alnylam Pharmaceuticals, Inc.

Compare with peers

Explore